Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials
Author(s) -
Joseph P. Broderick,
Yuko Y. Palesch,
Andrew M. Demchuk,
Sharon D. Yeatts,
Pooja Khatri,
Michael D. Hill,
Edward C. Jauch,
Tudor Jovin,
Bernard Yan,
Rüdiger von Kummer,
Carlos A. Molina,
Mayank Goyal,
Mikaël Mazighi,
Wouter J. Schonewille,
Stefan T. Engelter,
Craig S. Anderson,
Judith Spilker,
Janice Carrozzella,
L. Scott Janis,
Lydia D. Foster,
Thomas A. Tomsick
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.005952
Subject(s) - medicine , stroke (engine) , clinical trial , intensive care medicine , mechanical engineering , engineering
We explored changes in the patient population and practice of endovascular therapy during the course of the Interventional Management of Stroke (IMS) III Trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom